Antimullerian Hormone in Endometriomas

NCT02669628 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2018-02-23

No results posted yet for this study

Summary

The purpose of this multicenter study is to evaluate the ovarian reserve after alcohol sclerotherapy of endometriomas versus conventional surgery.

Conditions

  • Endometriomas

Interventions

PROCEDURE

Surgical technique

Laparoscopic surgery

PROCEDURE

Alcohol sclerotherapy

US-guided sclerotherapy

Sponsors & Collaborators

  • Roche Diagnostic Ltd.

    collaborator INDUSTRY
  • Hospital Universitari de Bellvitge

    lead OTHER

Principal Investigators

  • Amparo Garcia-Tejedor, MDPhD · Hospital de Bellvitge. IDIBELL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2018-01-31
Completion
2018-01-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02669628 on ClinicalTrials.gov